arginyl-glycyl-aspartic acid has been researched along with Sepsis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Curley, GF; Kerrigan, SW; Nader, D | 1 |
Chen, Z; Ding, X; Jin, S; Li, Q; Ren, H; Tong, Y; Wang, X; Zhao, X | 1 |
Hyun, YM; Kim, M; Lerman, YV; Pietropaoli, AP; Sarangi, PP | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Sepsis
Article | Year |
---|---|
A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?
Topics: Bacterial Infections; Humans; Integrins; Mycoses; Oligopeptides; Sepsis; Virus Diseases | 2020 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Sepsis
Article | Year |
---|---|
RGD peptides protects against acute lung injury in septic mice through Wisp1-integrin β6 pathway inhibition.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Capillaries; CCN Intercellular Signaling Proteins; Disease Models, Animal; Immunoprecipitation; Integrin beta Chains; Interleukin-6; Lung; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Proto-Oncogene Proteins; Sepsis; Tumor Necrosis Factor-alpha | 2015 |
Role of β1 integrin in tissue homing of neutrophils during sepsis.
Topics: Animals; Anti-Infective Agents; CD18 Antigens; Cell Movement; Humans; Integrin beta1; Ligation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; Neutrophil Infiltration; Neutrophils; Oligopeptides; Sepsis; Up-Regulation | 2012 |